Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of T cell mediated immunity (GO:0002710) | 9.06440534 |
2 | relaxation of smooth muscle (GO:0044557) | 8.05064307 |
3 | negative regulation of cAMP-mediated signaling (GO:0043951) | 7.96109835 |
4 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 7.87058996 |
5 | desmosome organization (GO:0002934) | 7.72985658 |
6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.48438029 |
7 | negative regulation of cell killing (GO:0031342) | 7.48438029 |
8 | glial cell proliferation (GO:0014009) | 7.26794758 |
9 | negative regulation of muscle hypertrophy (GO:0014741) | 7.03646486 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.88376880 |
11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.82953376 |
12 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 6.71074625 |
13 | regulation of hypersensitivity (GO:0002883) | 6.66867035 |
14 | positive regulation of T cell cytokine production (GO:0002726) | 6.61960591 |
15 | negative regulation of lipase activity (GO:0060192) | 6.50196176 |
16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.38276738 |
17 | negative regulation of interleukin-2 production (GO:0032703) | 6.36082400 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.31687913 |
19 | cellular response to interleukin-15 (GO:0071350) | 6.19506067 |
20 | regulation of T cell chemotaxis (GO:0010819) | 6.14114466 |
21 | positive regulation of T cell chemotaxis (GO:0010820) | 6.14114466 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.07765182 |
23 | relaxation of cardiac muscle (GO:0055119) | 6.02700270 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.94654142 |
25 | positive regulation of microtubule polymerization (GO:0031116) | 5.88673083 |
26 | response to interleukin-15 (GO:0070672) | 5.88499121 |
27 | activated T cell proliferation (GO:0050798) | 5.77357014 |
28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.73023577 |
29 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.63440246 |
30 | positive thymic T cell selection (GO:0045059) | 5.50518451 |
31 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 5.44101195 |
32 | leukocyte aggregation (GO:0070486) | 5.39723699 |
33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 5.32571369 |
34 | interferon-gamma production (GO:0032609) | 5.29307441 |
35 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.29085198 |
36 | positive regulation of transforming growth factor beta production (GO:0071636) | 5.21725114 |
37 | neutrophil activation involved in immune response (GO:0002283) | 5.13362679 |
38 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 5.06061306 |
39 | regulation of T cell tolerance induction (GO:0002664) | 4.92725901 |
40 | positive regulation of type 2 immune response (GO:0002830) | 4.88266153 |
41 | negative regulation of smooth muscle contraction (GO:0045986) | 4.85561014 |
42 | regulation of gamma-delta T cell activation (GO:0046643) | 4.66323078 |
43 | mammary gland alveolus development (GO:0060749) | 4.65617415 |
44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.61113698 |
45 | termination of signal transduction (GO:0023021) | 4.59653854 |
46 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.58281302 |
47 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.58281302 |
48 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 4.53452618 |
49 | positive regulation of interleukin-10 production (GO:0032733) | 4.47724544 |
50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.45254280 |
51 | macrophage activation involved in immune response (GO:0002281) | 4.41966682 |
52 | negative T cell selection (GO:0043383) | 4.41450061 |
53 | negative thymic T cell selection (GO:0045060) | 4.41226529 |
54 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 4.38293972 |
55 | regulation of T cell cytokine production (GO:0002724) | 4.37776884 |
56 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.36321703 |
57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.34327464 |
58 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.28136851 |
59 | negative regulation of interferon-gamma production (GO:0032689) | 4.24173578 |
60 | positive regulation by symbiont of host defense response (GO:0052509) | 4.22558627 |
61 | modulation by symbiont of host defense response (GO:0052031) | 4.22558627 |
62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.22558627 |
63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.22558627 |
64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.22558627 |
65 | modulation by symbiont of host immune response (GO:0052553) | 4.22558627 |
66 | detection of bacterium (GO:0016045) | 4.22487850 |
67 | lymphocyte chemotaxis (GO:0048247) | 4.21616141 |
68 | keratinocyte development (GO:0003334) | 4.20883069 |
69 | detection of other organism (GO:0098543) | 4.19056031 |
70 | neutrophil activation (GO:0042119) | 4.15302162 |
71 | T cell migration (GO:0072678) | 4.13471307 |
72 | cellular extravasation (GO:0045123) | 4.08144879 |
73 | thymic T cell selection (GO:0045061) | 4.00925046 |
74 | positive regulation of tolerance induction (GO:0002645) | 3.99786976 |
75 | B cell receptor signaling pathway (GO:0050853) | 3.97637069 |
76 | positive T cell selection (GO:0043368) | 3.97563766 |
77 | regulation of B cell differentiation (GO:0045577) | 3.96855296 |
78 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 3.95760403 |
79 | granulocyte activation (GO:0036230) | 3.92574673 |
80 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.86586684 |
81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.81535042 |
82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.78311466 |
83 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.77606745 |
84 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.73928469 |
85 | positive regulation of granulocyte differentiation (GO:0030854) | 3.72360686 |
86 | myeloid cell activation involved in immune response (GO:0002275) | 3.69673105 |
87 | keratinocyte proliferation (GO:0043616) | 3.69603138 |
88 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.68019095 |
89 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.63015688 |
90 | microglial cell activation (GO:0001774) | 3.61456655 |
91 | mammary gland epithelial cell proliferation (GO:0033598) | 3.61454602 |
92 | regulation of axon regeneration (GO:0048679) | 3.60247709 |
93 | regulation of neuron projection regeneration (GO:0070570) | 3.60247709 |
94 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.60122085 |
95 | positive regulation of B cell mediated immunity (GO:0002714) | 3.60122085 |
96 | positive regulation of interleukin-4 production (GO:0032753) | 3.59889070 |
97 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.58242171 |
98 | establishment of skin barrier (GO:0061436) | 3.55722593 |
99 | cornea development in camera-type eye (GO:0061303) | 3.55570740 |
100 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 3.54404826 |
101 | relaxation of muscle (GO:0090075) | 3.53900638 |
102 | type I interferon signaling pathway (GO:0060337) | 3.53837818 |
103 | cellular response to type I interferon (GO:0071357) | 3.53837818 |
104 | response to type I interferon (GO:0034340) | 3.52579033 |
105 | response to UV-B (GO:0010224) | 3.49885092 |
106 | negative regulation of interleukin-12 production (GO:0032695) | 3.48914877 |
107 | mast cell activation (GO:0045576) | 3.48714682 |
108 | regulation of tolerance induction (GO:0002643) | 3.45226773 |
109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45168926 |
110 | leukocyte degranulation (GO:0043299) | 3.42290891 |
111 | regulation of transforming growth factor beta production (GO:0071634) | 3.41529276 |
112 | immunoglobulin mediated immune response (GO:0016064) | 3.40036608 |
113 | T cell receptor signaling pathway (GO:0050852) | 3.39763543 |
114 | embryonic body morphogenesis (GO:0010172) | 3.38797647 |
115 | positive regulation of T cell migration (GO:2000406) | 3.38755653 |
116 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.38093037 |
117 | positive regulation of mast cell activation (GO:0033005) | 3.37112029 |
118 | regulation of water loss via skin (GO:0033561) | 3.34016147 |
119 | positive regulation of hair cycle (GO:0042635) | 3.32301966 |
120 | positive regulation of hair follicle development (GO:0051798) | 3.32301966 |
121 | respiratory burst (GO:0045730) | 3.29547165 |
122 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.29445732 |
123 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.27708559 |
124 | negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744) | 3.27261492 |
125 | negative regulation of muscle contraction (GO:0045932) | 3.26759559 |
126 | regulation of cell killing (GO:0031341) | 3.25495106 |
127 | regulation of receptor recycling (GO:0001919) | 3.24045376 |
128 | regulation of interleukin-10 production (GO:0032653) | 3.23843938 |
129 | detection of external biotic stimulus (GO:0098581) | 3.23198256 |
130 | positive regulation of B cell differentiation (GO:0045579) | 3.21687517 |
131 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.19149787 |
132 | cellular defense response (GO:0006968) | 3.18071639 |
133 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.17957736 |
134 | positive regulation of neutrophil migration (GO:1902624) | 3.17957736 |
135 | cellular response to zinc ion (GO:0071294) | 3.17320080 |
136 | negative regulation of adaptive immune response (GO:0002820) | 3.16417253 |
137 | positive regulation of odontogenesis (GO:0042482) | 3.15985390 |
138 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15972062 |
139 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.15857398 |
140 | positive regulation of cell killing (GO:0031343) | 3.15204991 |
141 | response to peptidoglycan (GO:0032494) | 3.13119223 |
142 | regulation of mast cell degranulation (GO:0043304) | 3.11437572 |
143 | basement membrane organization (GO:0071711) | 3.10166886 |
144 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09936189 |
145 | regulation of T-helper 1 type immune response (GO:0002825) | 3.09826084 |
146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09315521 |
147 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.07299049 |
148 | response to host immune response (GO:0052572) | 3.06750802 |
149 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06750802 |
150 | negative regulation of phagocytosis (GO:0050765) | 3.04734207 |
151 | eyelid development in camera-type eye (GO:0061029) | 3.04507125 |
152 | cytidine deamination (GO:0009972) | 3.04374871 |
153 | cytidine metabolic process (GO:0046087) | 3.04374871 |
154 | cytidine catabolic process (GO:0006216) | 3.04374871 |
155 | regulation of mast cell activation (GO:0033003) | 2.97985811 |
156 | detection of biotic stimulus (GO:0009595) | 2.95498605 |
157 | T cell selection (GO:0045058) | 2.94519407 |
158 | lymphocyte migration (GO:0072676) | 2.94020734 |
159 | positive regulation of isotype switching (GO:0045830) | 2.93998034 |
160 | positive regulation of cytokine production involved in immune response (GO:0002720) | 2.93943145 |
161 | negative regulation of innate immune response (GO:0045824) | 2.93303262 |
162 | dendritic cell chemotaxis (GO:0002407) | 2.91952906 |
163 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.90573342 |
164 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.90289024 |
165 | centrosome localization (GO:0051642) | 2.90185385 |
166 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90165903 |
167 | T cell proliferation (GO:0042098) | 2.89889637 |
168 | macrophage activation (GO:0042116) | 2.89611889 |
169 | positive regulation of lymphocyte migration (GO:2000403) | 2.89521865 |
170 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89513336 |
171 | regulation of T cell migration (GO:2000404) | 2.87971125 |
172 | response to host defenses (GO:0052200) | 2.87835267 |
173 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87835267 |
174 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.82211541 |
175 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.77962806 |
176 | signal complex assembly (GO:0007172) | 2.77198542 |
177 | positive regulation of immunoglobulin production (GO:0002639) | 2.75503026 |
178 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.75078711 |
179 | body morphogenesis (GO:0010171) | 2.74085747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.69244511 |
2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.54929497 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.32070879 |
4 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.15379090 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.11266833 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03279918 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81423791 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.69153116 |
9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.60559898 |
10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.23965571 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.16064231 |
12 | MYB_26560356_Chip-Seq_TH2_Human | 2.88713287 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79533857 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75031627 |
15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62784748 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60392540 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.58239504 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52868557 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.45478934 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44822642 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.43094946 |
22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.38473659 |
23 | MYB_26560356_Chip-Seq_TH1_Human | 2.36933470 |
24 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.35309662 |
25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.34696131 |
26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26471124 |
27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.21482797 |
28 | MYC_22102868_ChIP-Seq_BL_Human | 2.20948791 |
29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.18111332 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11888710 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11743929 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.08814153 |
33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07545383 |
34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.98375716 |
35 | MAF_26560356_Chip-Seq_TH2_Human | 1.91956299 |
36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86892014 |
37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82684354 |
38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82559363 |
39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76384592 |
40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75786551 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71044570 |
42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.69628588 |
43 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67614069 |
44 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63920483 |
45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.63478109 |
46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60146133 |
47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60121085 |
48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59327132 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57173039 |
50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56945564 |
51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56281302 |
52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55890334 |
53 | RXR_22108803_ChIP-Seq_LS180_Human | 1.52857952 |
54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50657642 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47770271 |
56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45957760 |
57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45026281 |
58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43666468 |
59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40789070 |
60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38921075 |
61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38921075 |
62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38920611 |
63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38374277 |
64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37889352 |
65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37209202 |
66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34925423 |
67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34894469 |
68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34157528 |
69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34115587 |
70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32955587 |
71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32923178 |
72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31329377 |
73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31030643 |
74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29876730 |
75 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29524166 |
76 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.28514333 |
77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28245774 |
78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26982235 |
79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26144041 |
80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24838020 |
81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23547851 |
82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23047588 |
83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22994719 |
84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22183118 |
85 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20651992 |
86 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20651992 |
87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19463275 |
88 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.19148432 |
89 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.19007079 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18920223 |
91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18019983 |
92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16356338 |
93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15775763 |
94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15758603 |
95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14818882 |
96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14310624 |
97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13958826 |
98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13450778 |
99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11631652 |
100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10991883 |
101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09757006 |
102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08584208 |
103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08521559 |
104 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.08412529 |
105 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08311475 |
106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08223802 |
107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07979120 |
108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07584900 |
109 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07578938 |
110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07562284 |
111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06120496 |
112 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05631102 |
113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05518450 |
114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05444803 |
115 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05285708 |
116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05113955 |
117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04688862 |
118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04524266 |
119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04158710 |
120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03964532 |
121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03877466 |
122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02977322 |
123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02316413 |
124 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00142028 |
125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99931883 |
126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99767315 |
127 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98387646 |
128 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97879001 |
129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96191949 |
130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95648941 |
131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93341421 |
132 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93246559 |
133 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92950684 |
134 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91662731 |
135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91618635 |
136 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.91016302 |
137 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90538224 |
138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90492032 |
139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90292643 |
140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90200569 |
141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89734895 |
142 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89405733 |
143 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89072751 |
144 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88652782 |
145 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88409894 |
146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87659528 |
147 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87451823 |
148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87042081 |
149 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86205482 |
150 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85665337 |
151 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84554821 |
152 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84140565 |
153 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83383495 |
154 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83135893 |
155 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82131307 |
156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81850401 |
157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81548478 |
158 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80142760 |
159 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80021484 |
160 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.79322133 |
161 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78675055 |
162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78614739 |
163 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78338873 |
164 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.78083579 |
165 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.77756592 |
166 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77133776 |
167 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77092477 |
168 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77053621 |
169 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76676555 |
170 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75634111 |
171 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.75417639 |
172 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75338711 |
173 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75081659 |
174 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.74892588 |
175 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74718657 |
176 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74647424 |
177 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.74221272 |
178 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73822510 |
179 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.73805308 |
180 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.73751996 |
181 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73333560 |
182 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.73021671 |
183 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.72963735 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 5.18273604 |
2 | MP0005671_abnormal_response_to | 4.59416653 |
3 | MP0004381_abnormal_hair_follicle | 4.28868537 |
4 | MP0001835_abnormal_antigen_presentation | 4.07463930 |
5 | MP0003436_decreased_susceptibility_to | 3.93716030 |
6 | MP0002796_impaired_skin_barrier | 3.83526838 |
7 | MP0006082_CNS_inflammation | 3.81289022 |
8 | MP0002098_abnormal_vibrissa_morphology | 3.65396443 |
9 | MP0003941_abnormal_skin_development | 3.52807646 |
10 | MP0003705_abnormal_hypodermis_morpholog | 3.36507155 |
11 | MP0002009_preneoplasia | 2.92760604 |
12 | MP0003950_abnormal_plasma_membrane | 2.78693526 |
13 | MP0002419_abnormal_innate_immunity | 2.77489385 |
14 | MP0004947_skin_inflammation | 2.69887223 |
15 | MP0000579_abnormal_nail_morphology | 2.68954855 |
16 | MP0000685_abnormal_immune_system | 2.60924702 |
17 | MP0005464_abnormal_platelet_physiology | 2.53021443 |
18 | MP0008961_abnormal_basal_metabolism | 2.44537544 |
19 | MP0009333_abnormal_splenocyte_physiolog | 2.42866695 |
20 | MP0003183_abnormal_peptide_metabolism | 2.36739625 |
21 | MP0003959_abnormal_lean_body | 2.36034535 |
22 | MP0002398_abnormal_bone_marrow | 2.33189584 |
23 | MP0002405_respiratory_system_inflammati | 2.31369611 |
24 | MP0000627_abnormal_mammary_gland | 2.27829315 |
25 | MP0004185_abnormal_adipocyte_glucose | 2.14343730 |
26 | MP0003300_gastrointestinal_ulcer | 2.14136762 |
27 | MP0000716_abnormal_immune_system | 2.12720924 |
28 | MP0001881_abnormal_mammary_gland | 2.05134168 |
29 | MP0005085_abnormal_gallbladder_physiolo | 1.99843340 |
30 | MP0003303_peritoneal_inflammation | 1.99010906 |
31 | MP0010155_abnormal_intestine_physiology | 1.92658762 |
32 | MP0002060_abnormal_skin_morphology | 1.91823350 |
33 | MP0005501_abnormal_skin_physiology | 1.88752544 |
34 | MP0001533_abnormal_skeleton_physiology | 1.88134600 |
35 | MP0002132_abnormal_respiratory_system | 1.88131202 |
36 | MP0001216_abnormal_epidermal_layer | 1.86364477 |
37 | MP0000689_abnormal_spleen_morphology | 1.85363606 |
38 | MP0002837_dystrophic_cardiac_calcinosis | 1.82521854 |
39 | MP0003453_abnormal_keratinocyte_physiol | 1.80854895 |
40 | MP0001845_abnormal_inflammatory_respons | 1.74414248 |
41 | MP0003866_abnormal_defecation | 1.74027459 |
42 | MP0005408_hypopigmentation | 1.68329974 |
43 | MP0002429_abnormal_blood_cell | 1.67611379 |
44 | MP0002006_tumorigenesis | 1.64066198 |
45 | MP0002277_abnormal_respiratory_mucosa | 1.63257749 |
46 | MP0001873_stomach_inflammation | 1.59506464 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.56781155 |
48 | MP0003566_abnormal_cell_adhesion | 1.52706049 |
49 | MP0001661_extended_life_span | 1.52404121 |
50 | MP0003828_pulmonary_edema | 1.50630258 |
51 | MP0004859_abnormal_synaptic_plasticity | 1.50342218 |
52 | MP0003172_abnormal_lysosome_physiology | 1.49845790 |
53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48169223 |
54 | MP0003252_abnormal_bile_duct | 1.47414741 |
55 | MP0001853_heart_inflammation | 1.44300910 |
56 | MP0000427_abnormal_hair_cycle | 1.43970614 |
57 | MP0002396_abnormal_hematopoietic_system | 1.41774435 |
58 | MP0000377_abnormal_hair_follicle | 1.39794058 |
59 | MP0003936_abnormal_reproductive_system | 1.39026266 |
60 | MP0006054_spinal_hemorrhage | 1.38556923 |
61 | MP0003724_increased_susceptibility_to | 1.37196590 |
62 | MP0004510_myositis | 1.37056431 |
63 | MP0000858_altered_metastatic_potential | 1.36509305 |
64 | MP0004883_abnormal_blood_vessel | 1.36293533 |
65 | MP0008469_abnormal_protein_level | 1.35387086 |
66 | MP0004858_abnormal_nervous_system | 1.35079756 |
67 | MP0000762_abnormal_tongue_morphology | 1.34284653 |
68 | MP0000367_abnormal_coat/_hair | 1.34155031 |
69 | MP0005365_abnormal_bile_salt | 1.30267961 |
70 | MP0002148_abnormal_hypersensitivity_rea | 1.24348586 |
71 | MP0000465_gastrointestinal_hemorrhage | 1.23583062 |
72 | MP0010352_gastrointestinal_tract_polyps | 1.23015902 |
73 | MP0003763_abnormal_thymus_physiology | 1.20769083 |
74 | MP0003191_abnormal_cellular_cholesterol | 1.20456241 |
75 | MP0002998_abnormal_bone_remodeling | 1.18010068 |
76 | MP0001851_eye_inflammation | 1.17562290 |
77 | MP0010771_integument_phenotype | 1.17236976 |
78 | MP0005310_abnormal_salivary_gland | 1.16775398 |
79 | MP0004270_analgesia | 1.16325872 |
80 | MP0001501_abnormal_sleep_pattern | 1.15753350 |
81 | MP0003690_abnormal_glial_cell | 1.12995820 |
82 | MP0009785_altered_susceptibility_to | 1.09736870 |
83 | MP0005647_abnormal_sex_gland | 1.09443691 |
84 | MP0003045_fibrosis | 1.05662903 |
85 | MP0002896_abnormal_bone_mineralization | 1.05199316 |
86 | MP0000751_myopathy | 1.03655689 |
87 | MP0004233_abnormal_muscle_weight | 1.02257710 |
88 | MP0000490_abnormal_crypts_of | 1.00872813 |
89 | MP0001340_abnormal_eyelid_morphology | 1.00592954 |
90 | MP0001800_abnormal_humoral_immune | 1.00150910 |
91 | MP0002166_altered_tumor_susceptibility | 0.97935009 |
92 | MP0001819_abnormal_immune_cell | 0.97375615 |
93 | MP0003938_abnormal_ear_development | 0.97026246 |
94 | MP0005000_abnormal_immune_tolerance | 0.94979905 |
95 | MP0005451_abnormal_body_composition | 0.94764936 |
96 | MP0009763_increased_sensitivity_to | 0.94731465 |
97 | MP0010678_abnormal_skin_adnexa | 0.94364919 |
98 | MP0001790_abnormal_immune_system | 0.93768897 |
99 | MP0005387_immune_system_phenotype | 0.93768897 |
100 | MP0005025_abnormal_response_to | 0.93281418 |
101 | MP0008260_abnormal_autophagy | 0.93060205 |
102 | MP0005166_decreased_susceptibility_to | 0.91342640 |
103 | MP0004130_abnormal_muscle_cell | 0.90984079 |
104 | MP0000609_abnormal_liver_physiology | 0.88096779 |
105 | MP0002723_abnormal_immune_serum | 0.88057254 |
106 | MP0002722_abnormal_immune_system | 0.87688305 |
107 | MP0005360_urolithiasis | 0.87656819 |
108 | MP0002139_abnormal_hepatobiliary_system | 0.87620269 |
109 | MP0002254_reproductive_system_inflammat | 0.87226223 |
110 | MP0001765_abnormal_ion_homeostasis | 0.87063410 |
111 | MP0003448_altered_tumor_morphology | 0.86997207 |
112 | MP0001663_abnormal_digestive_system | 0.86828552 |
113 | MP0005275_abnormal_skin_tensile | 0.86408011 |
114 | MP0003635_abnormal_synaptic_transmissio | 0.86222730 |
115 | MP0000647_abnormal_sebaceous_gland | 0.86191922 |
116 | MP0009931_abnormal_skin_appearance | 0.86140541 |
117 | MP0004019_abnormal_vitamin_homeostasis | 0.85347338 |
118 | MP0003633_abnormal_nervous_system | 0.84108912 |
119 | MP0005164_abnormal_response_to | 0.83963793 |
120 | MP0001986_abnormal_taste_sensitivity | 0.83267679 |
121 | MP0002332_abnormal_exercise_endurance | 0.81580926 |
122 | MP0000467_abnormal_esophagus_morphology | 0.81470916 |
123 | MP0009278_abnormal_bone_marrow | 0.81358662 |
124 | MP0001849_ear_inflammation | 0.81109515 |
125 | MP0002877_abnormal_melanocyte_morpholog | 0.79145948 |
126 | MP0002933_joint_inflammation | 0.77488986 |
127 | MP0005165_increased_susceptibility_to | 0.77322909 |
128 | MP0000015_abnormal_ear_pigmentation | 0.76161960 |
129 | MP0000703_abnormal_thymus_morphology | 0.75387848 |
130 | MP0004142_abnormal_muscle_tone | 0.74591710 |
131 | MP0002420_abnormal_adaptive_immunity | 0.73689787 |
132 | MP0001191_abnormal_skin_condition | 0.73304267 |
133 | MP0000383_abnormal_hair_follicle | 0.71269736 |
134 | MP0000470_abnormal_stomach_morphology | 0.71166599 |
135 | MP0003880_abnormal_central_pattern | 0.69662988 |
136 | MP0005390_skeleton_phenotype | 0.69139225 |
137 | MP0001666_abnormal_nutrient_absorption | 0.69130831 |
138 | MP0002136_abnormal_kidney_physiology | 0.68946440 |
139 | MP0009764_decreased_sensitivity_to | 0.67404141 |
140 | MP0002452_abnormal_antigen_presenting | 0.67322774 |
141 | MP0002970_abnormal_white_adipose | 0.66367468 |
142 | MP0000537_abnormal_urethra_morphology | 0.65760762 |
143 | MP0005397_hematopoietic_system_phenotyp | 0.65119020 |
144 | MP0001545_abnormal_hematopoietic_system | 0.65119020 |
145 | MP0004808_abnormal_hematopoietic_stem | 0.65014052 |
146 | MP0003075_altered_response_to | 0.65009467 |
147 | MP0002019_abnormal_tumor_incidence | 0.64963794 |
148 | MP0002572_abnormal_emotion/affect_behav | 0.64286781 |
149 | MP0002693_abnormal_pancreas_physiology | 0.61697962 |
150 | MP0000249_abnormal_blood_vessel | 0.61079732 |
151 | MP0005083_abnormal_biliary_tract | 0.60311582 |
152 | MP0009765_abnormal_xenobiotic_induced | 0.58972503 |
153 | MP0003795_abnormal_bone_structure | 0.54267022 |
154 | MP0005058_abnormal_lysosome_morphology | 0.52400927 |
155 | MP0008004_abnormal_stomach_pH | 0.51826215 |
156 | MP0003638_abnormal_response/metabolism_ | 0.50458822 |
157 | MP0008873_increased_physiological_sensi | 0.49771878 |
158 | MP0000920_abnormal_myelination | 0.48109901 |
159 | MP0000343_altered_response_to | 0.47226704 |
160 | MP0009115_abnormal_fat_cell | 0.45611414 |
161 | MP0000569_abnormal_digit_pigmentation | 0.45170256 |
162 | MP0003943_abnormal_hepatobiliary_system | 0.44846002 |
163 | MP0005381_digestive/alimentary_phenotyp | 0.44204421 |
164 | MP0005319_abnormal_enzyme/_coenzyme | 0.42797264 |
165 | MP0008874_decreased_physiological_sensi | 0.41546140 |
166 | MP0005376_homeostasis/metabolism_phenot | 0.40989889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Autoimmune hemolytic anemia (HP:0001890) | 9.88727943 |
2 | Lip pit (HP:0100267) | 6.61958213 |
3 | Natal tooth (HP:0000695) | 6.56712152 |
4 | Parakeratosis (HP:0001036) | 6.24884457 |
5 | T lymphocytopenia (HP:0005403) | 5.54804757 |
6 | Myositis (HP:0100614) | 5.26142653 |
7 | Recurrent abscess formation (HP:0002722) | 5.22867746 |
8 | Abnormality of T cell number (HP:0011839) | 5.20671539 |
9 | Epidermoid cyst (HP:0200040) | 5.15268234 |
10 | Abnormality of macrophages (HP:0004311) | 5.08889373 |
11 | Recurrent bacterial skin infections (HP:0005406) | 5.05243079 |
12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.74755126 |
13 | Abnormality of the nasal septum (HP:0000419) | 4.57309087 |
14 | Advanced eruption of teeth (HP:0006288) | 4.45480789 |
15 | Encephalitis (HP:0002383) | 4.42845811 |
16 | Morphological abnormality of the middle ear (HP:0008609) | 4.33885425 |
17 | Congenital, generalized hypertrichosis (HP:0004540) | 4.30717988 |
18 | Abnormality of nail color (HP:0100643) | 4.17117162 |
19 | Recurrent fungal infections (HP:0002841) | 4.14934443 |
20 | Spontaneous hematomas (HP:0007420) | 4.10186915 |
21 | Meningitis (HP:0001287) | 4.09128423 |
22 | Abnormality of T cells (HP:0002843) | 4.03250656 |
23 | Aplasia cutis congenita (HP:0001057) | 3.96403343 |
24 | Prolonged bleeding time (HP:0003010) | 3.81834783 |
25 | Obstructive lung disease (HP:0006536) | 3.80274888 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80274888 |
27 | Gastrointestinal infarctions (HP:0005244) | 3.80123244 |
28 | Dry hair (HP:0011359) | 3.78635005 |
29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.73596680 |
30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.71921908 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.71921908 |
32 | Renal cortical cysts (HP:0000803) | 3.68110935 |
33 | Palmoplantar hyperkeratosis (HP:0000972) | 3.61813425 |
34 | Recurrent skin infections (HP:0001581) | 3.59901453 |
35 | Increased IgM level (HP:0003496) | 3.58986122 |
36 | Palmar hyperkeratosis (HP:0010765) | 3.52859105 |
37 | Hypochromic microcytic anemia (HP:0004840) | 3.48996506 |
38 | Nasolacrimal duct obstruction (HP:0000579) | 3.46776256 |
39 | White forelock (HP:0002211) | 3.45538761 |
40 | Vasculitis (HP:0002633) | 3.39543291 |
41 | Abnormal number of erythroid precursors (HP:0012131) | 3.38171165 |
42 | Keratoconjunctivitis sicca (HP:0001097) | 3.34238118 |
43 | Hypotrichosis (HP:0001006) | 3.32241492 |
44 | Gingival bleeding (HP:0000225) | 3.32028112 |
45 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.29464784 |
46 | Chest pain (HP:0100749) | 3.27954019 |
47 | Panhypogammaglobulinemia (HP:0003139) | 3.26128715 |
48 | Pustule (HP:0200039) | 3.25831250 |
49 | Stomatitis (HP:0010280) | 3.22161088 |
50 | Hypochromic anemia (HP:0001931) | 3.21896628 |
51 | Gingivitis (HP:0000230) | 3.19537804 |
52 | Recurrent viral infections (HP:0004429) | 3.18712174 |
53 | Increased IgE level (HP:0003212) | 3.17944519 |
54 | Granulocytopenia (HP:0001913) | 3.17891683 |
55 | Leukocytosis (HP:0001974) | 3.17630418 |
56 | Pulmonary infiltrates (HP:0002113) | 3.17223145 |
57 | Abnormality of secondary sexual hair (HP:0009888) | 3.16553676 |
58 | Abnormality of the axillary hair (HP:0100134) | 3.16553676 |
59 | Inflammation of the large intestine (HP:0002037) | 3.15942820 |
60 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.14548555 |
61 | Epistaxis (HP:0000421) | 3.13637269 |
62 | Keratoconjunctivitis (HP:0001096) | 3.12457448 |
63 | Sparse scalp hair (HP:0002209) | 3.06694124 |
64 | Plantar hyperkeratosis (HP:0007556) | 3.03912037 |
65 | Gastrointestinal inflammation (HP:0004386) | 3.03804311 |
66 | Premature rupture of membranes (HP:0001788) | 3.03453771 |
67 | Abnormality of the lacrimal duct (HP:0011481) | 3.03226489 |
68 | Abnormality of the nasolacrimal system (HP:0000614) | 3.02733474 |
69 | Eosinophilia (HP:0001880) | 2.97551340 |
70 | Right ventricular cardiomyopathy (HP:0011663) | 2.97437888 |
71 | Joint swelling (HP:0001386) | 2.97215389 |
72 | Recurrent bronchitis (HP:0002837) | 2.96219454 |
73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95875517 |
74 | Urticaria (HP:0001025) | 2.94384736 |
75 | Abnormality of T cell physiology (HP:0011840) | 2.91423067 |
76 | Submucous cleft hard palate (HP:0000176) | 2.90090501 |
77 | Arterial thrombosis (HP:0004420) | 2.82211416 |
78 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.80735606 |
79 | Patchy hypopigmentation of hair (HP:0011365) | 2.76293026 |
80 | Anorexia (HP:0002039) | 2.74042860 |
81 | Abnormality of eosinophils (HP:0001879) | 2.72650816 |
82 | Episodic fever (HP:0001954) | 2.71177916 |
83 | Petechiae (HP:0000967) | 2.71142416 |
84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.67127774 |
85 | Osteolytic defects of the hand bones (HP:0009699) | 2.67127774 |
86 | Sparse eyelashes (HP:0000653) | 2.65426658 |
87 | Hemiplegia (HP:0002301) | 2.63240982 |
88 | Hemoptysis (HP:0002105) | 2.62536533 |
89 | Pulmonary embolism (HP:0002204) | 2.60113462 |
90 | Generalized hypopigmentation of hair (HP:0011358) | 2.56246373 |
91 | IgG deficiency (HP:0004315) | 2.53538524 |
92 | Severe combined immunodeficiency (HP:0004430) | 2.53054381 |
93 | Intrahepatic cholestasis (HP:0001406) | 2.51303812 |
94 | Prolonged partial thromboplastin time (HP:0003645) | 2.50565019 |
95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.47347490 |
96 | Fair hair (HP:0002286) | 2.45443169 |
97 | Muscle fiber atrophy (HP:0100295) | 2.39831240 |
98 | Hypergammaglobulinemia (HP:0010702) | 2.39451874 |
99 | Agammaglobulinemia (HP:0004432) | 2.37909270 |
100 | Purpura (HP:0000979) | 2.37877488 |
101 | Megalencephaly (HP:0001355) | 2.36857943 |
102 | Anophthalmia (HP:0000528) | 2.36671916 |
103 | Woolly hair (HP:0002224) | 2.32422079 |
104 | Microcytic anemia (HP:0001935) | 2.31172350 |
105 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30628628 |
106 | Asplenia (HP:0001746) | 2.29565978 |
107 | Type 2 muscle fiber atrophy (HP:0003554) | 2.28444546 |
108 | IgM deficiency (HP:0002850) | 2.28290032 |
109 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.25989481 |
110 | Nasal polyposis (HP:0100582) | 2.25567893 |
111 | Cellulitis (HP:0100658) | 2.24496692 |
112 | Colitis (HP:0002583) | 2.23897420 |
113 | Increased serum ferritin (HP:0003281) | 2.23812609 |
114 | Limb hypertonia (HP:0002509) | 2.21872410 |
115 | Angiofibromas (HP:0010615) | 2.20582056 |
116 | Adenoma sebaceum (HP:0009720) | 2.20582056 |
117 | Abnormal platelet volume (HP:0011876) | 2.20495757 |
118 | Autoimmune thrombocytopenia (HP:0001973) | 2.17106939 |
119 | Popliteal pterygium (HP:0009756) | 2.15836616 |
120 | Chronic otitis media (HP:0000389) | 2.14624305 |
121 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.13569727 |
122 | Hydroxyprolinuria (HP:0003080) | 2.12737399 |
123 | Abnormality of proline metabolism (HP:0010907) | 2.12737399 |
124 | Abnormality of the pleura (HP:0002103) | 2.10118788 |
125 | Abnormality of the fingertips (HP:0001211) | 2.10106283 |
126 | Short nail (HP:0001799) | 2.09284339 |
127 | Abnormality of binocular vision (HP:0011514) | 2.09069807 |
128 | Diplopia (HP:0000651) | 2.09069807 |
129 | Chronic diarrhea (HP:0002028) | 2.08081616 |
130 | Abnormality of iron homeostasis (HP:0011031) | 2.07888604 |
131 | Weak cry (HP:0001612) | 2.07410863 |
132 | Gangrene (HP:0100758) | 2.06540376 |
133 | Premature graying of hair (HP:0002216) | 2.06028638 |
134 | Acute hepatic failure (HP:0006554) | 2.05969091 |
135 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.05405132 |
136 | Fatigable weakness (HP:0003473) | 2.04958255 |
137 | Abnormality of the neuromuscular junction (HP:0003398) | 2.04958255 |
138 | Verrucae (HP:0200043) | 2.04607004 |
139 | Papilloma (HP:0012740) | 2.04607004 |
140 | Wide intermamillary distance (HP:0006610) | 2.04567127 |
141 | Hyperlipoproteinemia (HP:0010980) | 2.04377204 |
142 | Sepsis (HP:0100806) | 2.03153107 |
143 | Hoarse voice (HP:0001609) | 2.00104854 |
144 | Nonprogressive disorder (HP:0003680) | 1.99784210 |
145 | Glomerulopathy (HP:0100820) | 1.99766270 |
146 | Slow saccadic eye movements (HP:0000514) | 1.99531977 |
147 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98476448 |
148 | Orchitis (HP:0100796) | 1.96982559 |
149 | Combined immunodeficiency (HP:0005387) | 1.95731579 |
150 | Amaurosis fugax (HP:0100576) | 1.94448223 |
151 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92352050 |
152 | Vertigo (HP:0002321) | 1.92090403 |
153 | Ventricular tachycardia (HP:0004756) | 1.91218417 |
154 | Hypoplasia of the thymus (HP:0000778) | 1.89499340 |
155 | Viral hepatitis (HP:0006562) | 1.88870594 |
156 | Acne (HP:0001061) | 1.87574964 |
157 | Lymphoma (HP:0002665) | 1.87366221 |
158 | Supernumerary nipples (HP:0002558) | 1.86790817 |
159 | Preauricular pit (HP:0004467) | 1.86248832 |
160 | Periauricular skin pits (HP:0100277) | 1.86248832 |
161 | Papilledema (HP:0001085) | 1.84717932 |
162 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.84448459 |
163 | Acanthosis nigricans (HP:0000956) | 1.83006417 |
164 | Obstructive sleep apnea (HP:0002870) | 1.82406951 |
165 | Hyperglycemia (HP:0003074) | 1.81296820 |
166 | Distal lower limb amyotrophy (HP:0008944) | 1.77276336 |
167 | Abnormally folded helix (HP:0008544) | 1.76506543 |
168 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.76065585 |
169 | Poor suck (HP:0002033) | 1.75483377 |
170 | Athetosis (HP:0002305) | 1.75120078 |
171 | Abnormality of the common coagulation pathway (HP:0010990) | 1.75036727 |
172 | Hypoproteinemia (HP:0003075) | 1.74269828 |
173 | Overfolded helix (HP:0000396) | 1.74188478 |
174 | Mediastinal lymphadenopathy (HP:0100721) | 1.73725560 |
175 | Neurofibrillary tangles (HP:0002185) | 1.72946873 |
176 | Enlarged kidneys (HP:0000105) | 1.72547494 |
177 | Hypoglycemic seizures (HP:0002173) | 1.72348765 |
178 | Skin pits (HP:0100276) | 1.69380822 |
179 | Eczematoid dermatitis (HP:0000976) | 1.67240283 |
180 | Abnormal trabecular bone morphology (HP:0100671) | 1.66206016 |
181 | Retrobulbar optic neuritis (HP:0100654) | 1.65202749 |
182 | Optic neuritis (HP:0100653) | 1.65202749 |
183 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.64473023 |
184 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60641985 |
185 | Femoral bowing (HP:0002980) | 1.58856395 |
186 | Lymphopenia (HP:0001888) | 1.58283030 |
187 | Xanthomatosis (HP:0000991) | 1.57966546 |
188 | Nasal speech (HP:0001611) | 1.57474647 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.52709285 |
2 | PIK3CG | 4.39136550 |
3 | EEF2K | 4.11243125 |
4 | RIPK4 | 3.97566283 |
5 | TXK | 3.65753028 |
6 | MAP3K13 | 3.51761434 |
7 | MST1R | 3.24234723 |
8 | MAP3K9 | 3.21202370 |
9 | FGFR2 | 2.97143506 |
10 | FES | 2.75412576 |
11 | MAPKAPK3 | 2.58673569 |
12 | PRPF4B | 2.49801847 |
13 | ITK | 2.34838078 |
14 | EPHB1 | 2.33920228 |
15 | ZAP70 | 2.22316859 |
16 | BTK | 2.19118524 |
17 | IRAK4 | 2.14098097 |
18 | TAOK3 | 2.13979413 |
19 | TNK2 | 2.10515810 |
20 | JAK1 | 2.10233988 |
21 | GRK6 | 2.05508129 |
22 | MAP2K3 | 2.05266593 |
23 | TRPM7 | 1.90521684 |
24 | INSRR | 1.89341014 |
25 | MAP3K3 | 1.86567913 |
26 | FGFR4 | 1.85549426 |
27 | RPS6KB2 | 1.85428371 |
28 | JAK3 | 1.84311164 |
29 | SIK3 | 1.67245288 |
30 | GRK7 | 1.61853098 |
31 | MAPKAPK5 | 1.60112587 |
32 | MAP3K2 | 1.57336976 |
33 | DYRK3 | 1.54663348 |
34 | MST4 | 1.53728011 |
35 | EPHB2 | 1.52304658 |
36 | PRKD1 | 1.51319867 |
37 | MAP3K12 | 1.49758066 |
38 | TYRO3 | 1.45197408 |
39 | TEC | 1.43159601 |
40 | RPS6KA4 | 1.42848948 |
41 | TLK1 | 1.40164052 |
42 | MAP3K14 | 1.39227524 |
43 | EPHA4 | 1.39225314 |
44 | MARK2 | 1.35280585 |
45 | MAP3K11 | 1.33460719 |
46 | MARK3 | 1.31813555 |
47 | TRIB3 | 1.26741027 |
48 | NTRK2 | 1.24765566 |
49 | RPS6KA2 | 1.23563770 |
50 | LRRK2 | 1.21103010 |
51 | FGR | 1.19019585 |
52 | MOS | 1.18705547 |
53 | PDK1 | 1.16831919 |
54 | MAP3K7 | 1.16218187 |
55 | RET | 1.14982383 |
56 | HIPK2 | 1.13266540 |
57 | IKBKE | 1.13151037 |
58 | BMPR2 | 1.09170323 |
59 | FRK | 1.07924445 |
60 | CHUK | 1.05116493 |
61 | FYN | 1.05056504 |
62 | JAK2 | 1.03986642 |
63 | CSF1R | 1.01816066 |
64 | TAOK1 | 1.01640955 |
65 | MAP3K1 | 0.97798723 |
66 | TESK2 | 0.95209313 |
67 | HCK | 0.94105622 |
68 | IGF1R | 0.94069356 |
69 | TYK2 | 0.93762123 |
70 | STK10 | 0.93398379 |
71 | ERBB2 | 0.90885707 |
72 | KIT | 0.89711906 |
73 | ADRBK1 | 0.88983647 |
74 | PRKCH | 0.87411184 |
75 | SGK2 | 0.86380333 |
76 | PIM1 | 0.86338169 |
77 | MAP2K6 | 0.85576391 |
78 | MYLK | 0.84731165 |
79 | BLK | 0.84574526 |
80 | FGFR3 | 0.83469072 |
81 | KSR2 | 0.82065315 |
82 | LCK | 0.81720327 |
83 | SYK | 0.80649957 |
84 | SIK2 | 0.80429599 |
85 | MAPK15 | 0.80213734 |
86 | CDK12 | 0.79550293 |
87 | RPS6KC1 | 0.78950299 |
88 | RPS6KL1 | 0.78950299 |
89 | FER | 0.78622125 |
90 | STK38 | 0.77790516 |
91 | GRK5 | 0.77639195 |
92 | YES1 | 0.77260162 |
93 | RPS6KA6 | 0.75459863 |
94 | CAMK2D | 0.74686192 |
95 | LYN | 0.73106988 |
96 | MAP2K4 | 0.72646061 |
97 | MINK1 | 0.72382699 |
98 | TBK1 | 0.71627245 |
99 | CASK | 0.71083333 |
100 | PRKAA2 | 0.69085973 |
101 | TGFBR2 | 0.67606310 |
102 | RPS6KB1 | 0.66977122 |
103 | PTK6 | 0.66341632 |
104 | MAPK12 | 0.65985219 |
105 | BMX | 0.65896484 |
106 | PRKCQ | 0.64620069 |
107 | CSK | 0.64146228 |
108 | STK11 | 0.63751157 |
109 | PAK3 | 0.63670856 |
110 | PRKG1 | 0.63264552 |
111 | PAK4 | 0.61767066 |
112 | PTK2B | 0.61098198 |
113 | CDK4 | 0.60913468 |
114 | MET | 0.60746530 |
115 | SMG1 | 0.59495590 |
116 | IRAK1 | 0.59129914 |
117 | SGK494 | 0.58952866 |
118 | SGK223 | 0.58952866 |
119 | CAMKK1 | 0.58785797 |
120 | RPS6KA1 | 0.58571700 |
121 | INSR | 0.57730865 |
122 | GSK3A | 0.56929854 |
123 | NLK | 0.55762925 |
124 | CAMK4 | 0.55390013 |
125 | MAP2K7 | 0.53363624 |
126 | PRKCZ | 0.52467965 |
127 | EPHA3 | 0.52386970 |
128 | MAPK7 | 0.50851313 |
129 | CAMKK2 | 0.49933166 |
130 | PDPK1 | 0.49635763 |
131 | MAPK11 | 0.49126894 |
132 | ERN1 | 0.48963527 |
133 | DYRK1B | 0.48100495 |
134 | UHMK1 | 0.47629880 |
135 | MAP3K10 | 0.47382772 |
136 | IKBKB | 0.47088890 |
137 | MAPKAPK2 | 0.46839558 |
138 | SGK3 | 0.46307440 |
139 | * CDK3 | 0.46182691 |
140 | ROCK1 | 0.45393527 |
141 | ICK | 0.44734069 |
142 | KDR | 0.42918645 |
143 | CDK5 | 0.42458115 |
144 | AKT2 | 0.41596109 |
145 | TAOK2 | 0.41310423 |
146 | PRKD2 | 0.41022981 |
147 | * PRKCE | 0.40456446 |
148 | PKN1 | 0.40137072 |
149 | CAMK2A | 0.39019063 |
150 | VRK1 | 0.38451559 |
151 | MATK | 0.38438388 |
152 | MAP3K5 | 0.35957805 |
153 | CDK19 | 0.35941434 |
154 | RIPK1 | 0.34724496 |
155 | MELK | 0.33078053 |
156 | BRD4 | 0.31366711 |
157 | CDC42BPA | 0.29985355 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 6.60709227 |
2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.54865559 |
3 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 3.38480408 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.05244318 |
5 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.73019174 |
6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.64022757 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.62827566 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43064743 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42761268 |
10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.41532495 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.32962126 |
12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31562389 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30040774 |
14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.09970237 |
15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92562862 |
16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.89287300 |
17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.84553293 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80452607 |
19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.71740608 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64937462 |
21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.58360861 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54430083 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53301862 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44612847 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43496739 |
26 | Measles_Homo sapiens_hsa05162 | 1.38189290 |
27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35917719 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32569669 |
29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31363248 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28988553 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27256135 |
32 | Influenza A_Homo sapiens_hsa05164 | 1.24875106 |
33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22740767 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.20108508 |
35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17979756 |
36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14659304 |
37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14248862 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.13323831 |
39 | Renin secretion_Homo sapiens_hsa04924 | 1.07785618 |
40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07702440 |
41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00998376 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00589744 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99612935 |
44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97812562 |
45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97488576 |
46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95844784 |
47 | Shigellosis_Homo sapiens_hsa05131 | 0.92451633 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 0.92348115 |
49 | Legionellosis_Homo sapiens_hsa05134 | 0.88982793 |
50 | Apoptosis_Homo sapiens_hsa04210 | 0.88005784 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87110650 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86084031 |
53 | Phagosome_Homo sapiens_hsa04145 | 0.84879557 |
54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84275206 |
55 | Endocytosis_Homo sapiens_hsa04144 | 0.82307172 |
56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80785825 |
57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.80596995 |
58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79725793 |
59 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79293382 |
60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79066500 |
61 | Asthma_Homo sapiens_hsa05310 | 0.78980517 |
62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77769397 |
63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76595959 |
64 | Pertussis_Homo sapiens_hsa05133 | 0.75018833 |
65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73686478 |
66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73282980 |
67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73004452 |
68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72498061 |
69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72262314 |
70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71890481 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71822202 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71463764 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.70350262 |
74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69684661 |
75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68730558 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68064268 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.67698904 |
78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66431176 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65983758 |
80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65877215 |
81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65711356 |
82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63963012 |
83 | Bile secretion_Homo sapiens_hsa04976 | 0.63763578 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.63599815 |
85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63533116 |
86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63259945 |
87 | Melanogenesis_Homo sapiens_hsa04916 | 0.61808436 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.61266161 |
89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58753743 |
90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58687000 |
91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58430666 |
92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58322127 |
93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56984698 |
94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56241359 |
95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56171999 |
96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56096140 |
97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55847866 |
98 | Ribosome_Homo sapiens_hsa03010 | 0.55658343 |
99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54870788 |
100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53830489 |
101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53802021 |
102 | Salivary secretion_Homo sapiens_hsa04970 | 0.53700266 |
103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53324755 |
104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51715132 |
105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51712747 |
106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51384423 |
107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51298915 |
108 | Tuberculosis_Homo sapiens_hsa05152 | 0.51162452 |
109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50817178 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50143630 |
111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49826973 |
112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49499933 |
113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48383794 |
114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48198537 |
115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47795325 |
116 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47481269 |
117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47261718 |
118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47091115 |
119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46118950 |
120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45654091 |
121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44889513 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44872746 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44405001 |
124 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44264511 |
125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43843493 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42943615 |
127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42701713 |
128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42540646 |
129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42444606 |
130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41876756 |
131 | Mineral absorption_Homo sapiens_hsa04978 | 0.41660886 |
132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41266526 |
133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40754814 |
134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40307830 |
135 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39484738 |
136 | Lysosome_Homo sapiens_hsa04142 | 0.39444820 |
137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39429857 |
138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39292557 |
139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39290732 |
140 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39221277 |
141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38228893 |
142 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38172253 |
143 | Axon guidance_Homo sapiens_hsa04360 | 0.37340668 |
144 | Insulin resistance_Homo sapiens_hsa04931 | 0.37071968 |
145 | Insulin secretion_Homo sapiens_hsa04911 | 0.36735699 |
146 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36252614 |
147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35650739 |
148 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35382541 |
149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34820325 |
150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34528194 |
151 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34292591 |
152 | Malaria_Homo sapiens_hsa05144 | 0.33252238 |
153 | ABC transporters_Homo sapiens_hsa02010 | 0.33201675 |
154 | Adherens junction_Homo sapiens_hsa04520 | 0.32331118 |
155 | Glioma_Homo sapiens_hsa05214 | 0.32114712 |
156 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32073758 |
157 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31744660 |
158 | Taste transduction_Homo sapiens_hsa04742 | 0.31561586 |
159 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31468137 |
160 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31203596 |
161 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30965611 |
162 | Prostate cancer_Homo sapiens_hsa05215 | 0.30895469 |
163 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30197407 |
164 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29984905 |